Fair enough.
If I understand, it boils down to your conviction that this company will "flip the script", and despite the lack of steady, upward trending revenues - and in fact, the reverse: declining performance - will prove skeptics like me wrong, and become a significant winner. I have noted your own estimated "buy out" and share price numbers.
I'll admit, I have not been able to devine specifically what this conviction is based upon, other than general references to this emerging technology, and staggering billions of potential dollars that can presumably be realized if the flagship machine starts selling like hotcakes, but perhaps there is data that I either have not been able to find, or that I just don't fully comprehend.
So, time will tell - and, as the saying goes, "therein lies the rub", as that has been the watchword since at least 2009; and not to beat a dead horse, but as others have noted, your track record on some other OTC companies that shared some similar traits and trevails, has not been all that great - at least with regard to the ones I have looked at.
I just have not been able to overcome my doubts and take a flyer on this stock at it's relatively tiny price.
If I understand, it boils down to your conviction that this company will "flip the script", and despite the lack of steady, upward trending revenues - and in fact, the reverse: declining performance - will prove skeptics like me wrong, and become a significant winner. I have noted your own estimated "buy out" and share price numbers.
I'll admit, I have not been able to devine specifically what this conviction is based upon, other than general references to this emerging technology, and staggering billions of potential dollars that can presumably be realized if the flagship machine starts selling like hotcakes, but perhaps there is data that I either have not been able to find, or that I just don't fully comprehend.
So, time will tell - and, as the saying goes, "therein lies the rub", as that has been the watchword since at least 2009; and not to beat a dead horse, but as others have noted, your track record on some other OTC companies that shared some similar traits and trevails, has not been all that great - at least with regard to the ones I have looked at.
I just have not been able to overcome my doubts and take a flyer on this stock at it's relatively tiny price.
